Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation

被引:98
作者
Ortega, Nathalie [4 ]
Wang, Ke [1 ,2 ]
Ferrara, Napoleone [3 ]
Werb, Zena [4 ]
Vu, Thiennu H. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA
[3] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[4] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
OLD SKELETAL BIOLOGY; MICE LACKING; MULTICENTRIC OSTEOLYSIS; MULTIPLE ROLES; KEY REGULATOR; VEGF-A; CARTILAGE; OSSIFICATION; ANGIOGENESIS; COLLAGEN;
D O I
10.1242/dmm.004226
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Long bone development depends on endochondral bone formation, a complex process requiring exquisite balance between hypertrophic cartilage (HC) formation and its ossification. Dysregulation of this process may result in skeletal dysplasias and heterotopic ossification. Endochondral ossification requires the precise orchestration of HC vascularization, extracellular matrix remodeling, and the recruitment of osteoclasts and osteoblasts. Matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF) and osteoclasts have all been shown to regulate endochondral ossification, but how their function interrelates is not known. We have investigated the functional relationship among these regulators of endochondral ossification, demonstrating that they have complementary but non-overlapping functions. MMP-9, VEGF and osteoclast deficiency all cause impaired growth plate ossification resulting in the accumulation of HC. VEGF mRNA and protein expression are increased at the MMP-9-/- growth plate, and VEGF activity contributes to endochondral ossification since sequestration of VEGF by soluble receptors results in further inhibition of growth plate vascularization and ossification. However, VEGF bioavailability is still limited in MMP-9 deficiency, as exogenous VEGF is able to rescue the MMP-9-/- phenotype, demonstrating that MMP-9 may partially, but not fully, regulate VEGF bioavailability. The organization of the HC extracellular matrix at the MMP-9-/- growth plate is altered, supporting a role for MMP-9 in HC remodeling. Inhibition of VEGF impairs osteoclast recruitment, whereas MMP-9 deficiency leads to an accumulation of osteoclasts at the chondro-osseous junction. Growth plate ossification in osteoclast-deficient mice is impaired in the presence of normal MMP-9 expression, indicating that other osteoclastic functions are also necessary. Our data delineate the complementary interplay between MMP-9, VEGF and osteoclast function that is necessary for normal endochondral bone formation and provide a molecular framework for investigating the molecular defects contributing to disorders of endochondral bone formation.
引用
收藏
页码:224 / 235
页数:12
相关论文
共 52 条
[1]
Vascular endothelial growth factor receptors in osteoclast differentiation and function [J].
Aldridge, SE ;
Lennard, TWJ ;
Williams, JR ;
Birch, MA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (03) :793-798
[2]
Perlecan is essential for cartilage and cephalic development [J].
Arikawa-Hirasawa, E ;
Watanabe, H ;
Takami, H ;
Hassell, JR ;
Yamada, Y .
NATURE GENETICS, 1999, 23 (03) :354-358
[3]
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[4]
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage [J].
Billinghurst, RC ;
Dahlberg, L ;
Ionescu, M ;
Reiner, A ;
Bourne, R ;
Rorabeck, C ;
Mitchell, P ;
Hambor, J ;
Diekmann, O ;
Tschesche, H ;
Chen, J ;
VanWart, H ;
Poole, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1534-1545
[5]
Regulation of trophoblastic gelatinases by proto-oncogenes [J].
Bischof, P ;
Truong, K ;
Campana, A .
PLACENTA, 2003, 24 (2-3) :155-163
[6]
The new bone biology: Pathologic, molecular, and clinical correlates [J].
Cohen, M. Michael, Jr. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (23) :2646-2706
[7]
Cohen MM, 2000, J CRAN GENET DEV BIO, V20, P84
[8]
Cohen MM, 2000, J CRAN GENET DEV BIO, V20, P94
[9]
Cellular and molecular interactions regulating skeletogenesis [J].
Colnot, C .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 95 (04) :688-697
[10]
Increased bone formation in mice lacking plasminogen activators [J].
Daci, E ;
Everts, V ;
Torrekens, S ;
Van Herck, E ;
Tigchelaar-Gutterr, W ;
Bouillon, R ;
Carmeliet, G .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (07) :1167-1176